Toll interacting protein (TOLLIP) gene polymorphisms in patients with systemic sclerosis (SSc) associated interstitial lung disease (ILD): association with outcome and survival

被引：0
|
作者：
Schroeder, Niels [1 ]
Andrae, Jitka [1 ]
Knuth-Rehr, Diana [2 ]
Leja, Silke [2 ]
Hunzelmann, Nicolas [2 ]
Boerner, Eda [1 ]
Bonella, Francesco [1 ]
机构：
[1] Univ Duisburg Essen, Pneumonol Dept, Ctr Interstitial & Rare Lung Dis, Ruhrlandklin, Essen, Germany
[2] Univ Hosp Cologne, Dept Dermatol & Venereol, Cologne, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4261
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Toll Interacting Protein (TOLLIP) Gene Polymorphisms in Patients With Systemic Sclerosis (SSc) With and Without Interstitial Lung Disease (ILD): Association With Outcome and Survival
    Bonella, F.
    Schroeder, N.
    Knuth-Rehr, D.
    Leja, S.
    Moinzadeh, P.
    Hunzelmann, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
    Cottin, Vincent
    Brown, Kevin K.
    RESPIRATORY RESEARCH, 2019, 20 (1)
  • [3] Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
    Vincent Cottin
    Kevin K. Brown
    Respiratory Research, 20
  • [4] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Cole, Alice
    Denton, Christopher P.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2022, 8 (04) : 152 - 170
  • [5] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Alice Cole
    Christopher P. Denton
    Current Treatment Options in Rheumatology, 2022, 8 : 152 - 170
  • [6] Factors Associated With Progression of Interstitial Lung Disease in Patients With Systemic Sclerosis (SSc-ILD)
    Yosboot, A.
    Muangchan, C.
    Teerapuncharoen, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] Factors Associated With Symptomatic Interstitial Lung Disease in Patients With Systemic Sclerosis (SSc-ILD)
    Chaichatpornsuk, V.
    Teerapuncharoen, K.
    Muangchan, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Prevalence and Survival of Systemic Sclerosis (SSc) and Associated Interstitial Lung Disease (ILD) in Ontario, Canada over 10 Years
    Pope, Janet
    Quansah, Kobina
    Kolb, Martin
    Flavin, Jason
    Shazia, Hassan
    Seung, Soo Jin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): the SENSCIS trial
    Prasse, A.
    Distler, O.
    Highland, K. B.
    Gahlemann, M.
    Azuma, A.
    Mayes, M. D.
    Raghu, G.
    Sauter, W.
    Girard, M.
    Alves, M.
    Clerisme-Beaty, E.
    Kuwana, M.
    Maher, T. M.
    PNEUMOLOGIE, 2020, 74 : S57 - S58
  • [10] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): The SENSCIS Trial
    Distler, O.
    Highland, K. B.
    Gahlemann, M.
    Azuma, A.
    Fischer, A.
    Mayes, M.
    Raghu, G.
    Sauter, W.
    Girard, M.
    Alves, M.
    Clerisme-Beaty, E.
    Kuwana, M.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345